HIF‑1α silencing suppresses growth of lung adenocarcinoma A549 cells through induction of apoptosis

Liao,Hong‑Ying; Wang,Gui‑Ping; Huang,Shao‑Hong; Li,Yun; Cai,Song‑Wang; Zhang,Jian; Chen,Hui‑Guo; Wu,Wei‑Bin

doi:10.3892/mmr.2014.1910

2014-March Volume 9 Issue 3

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

2014-March Volume 9 Issue 3

Full Size Image

Article

HIF‑1α silencing suppresses growth of lung adenocarcinoma A549 cells through induction of apoptosis

Authors:
- Hong‑Ying Liao
- Gui‑Ping Wang
- Shao‑Hong Huang
- Yun Li
- Song‑Wang Cai
- Jian Zhang
- Hui‑Guo Chen
- Wei‑Bin Wu
View Affiliations / Copyright

Affiliations: Department of Thoracic Surgery, Clinical Research Center of Chest Tumor, Third Affiliated Hospital, Sun Yat‑sen University, Guangzhou, Guangdong 510630, P.R. China, Department of Pharmacy, Health College, Guangzhou Medical University, Guangzhou, Guangdong 510180, P.R. China
Pages: 911-915
|
Published online on: January 22, 2014

https://doi.org/10.3892/mmr.2014.1910
Expand metrics +

Abstract

Lung adenocarcinoma (AC) is one of the most deadly malignancies. The disease has a low five-year survival rate; therefore, the identification of novel therapeutic agents is required. This study aimed to investigate the effect of small interfering RNA (siRNA) targeting hypoxia‑inducible factor 1α (HIF‑1α) on the growth of AC A549 cells. A549 cells were transfected with various concentrations of HIF‑1α or control siRNA, and the effect on HIF‑1α expression was analyzed using quantitative polymerase chain reaction and western blot analysis. The effects of HIF-1α siRNA on growth inhibition and apoptosis were then assessed using standard methods. HIF‑1α siRNA treatment significantly reduced HIF‑1α mRNA and protein expression in A549 cells. Furthermore, the downregulation of HIF-1α expression inhibited the growth of A549 cells and induced apoptosis of A549 cells by upregulating caspase-3 expression. The present in vitro study demonstrates that the downregulation of HIF‑1α is capable of suppressing AC A549 cell growth, through the induction of apoptosis. This suggests that HIF‑1α inhibition may represent a promising strategy for the treatment of AC.

View Figures

View References

1	Kadara H, Kabbout M and Wistuba II: Pulmonary adenocarcinoma: a renewed entity in 2011. Respirology. 17:50–65. 2012. View Article : Google Scholar : PubMed/NCBI
2	Travis WD, Brambilla E, Noguchi M, et al; American Thoracic Society. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proc Am Thorac Soc. 8:381–385. 2011. View Article : Google Scholar
3	Hodkinson PS and Sethi T: Advances in the prevention and treatment of lung cancer. J R Coll Physicians Edinb. 41:142–149. 2011. View Article : Google Scholar : PubMed/NCBI
4	Mitsudomi T and Yatabe Y: Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer. Cancer Sci. 98:1817–1824. 2007. View Article : Google Scholar
5	de Mello RA, Marques DS, Medeiros R and Araújo AM: Epidermal growth factor receptor and K-Ras in non-small cell lung cancer-molecular pathways involved and targeted therapies. World J Clin Oncol. 2:367–376. 2011.PubMed/NCBI
6	Moran C: Importance of molecular features of non-small cell lung cancer for choice of treatment. Am J Pathol. 178:1940–1948. 2011. View Article : Google Scholar : PubMed/NCBI
7	Patiar S and Harris AL: Role of hypoxia-inducible factor-1alpha as a cancer therapy target. Endocr Relat Cancer. 13(Suppl 1): S61–S75. 2006. View Article : Google Scholar : PubMed/NCBI
8	Savai R, Schermuly RT, Voswinckel R, et al: HIF-1α attenuates tumor growth in spite of augmented vascularization in an A549 adenocarcinoma mouse model. Int J Oncol. 27:393–400. 2005.
9	Scortegagna M, Martin RJ, Kladney RD, Neumann RG and Arbeit JM: Hypoxia-inducible factor-1alpha suppresses squamous carcinogenic progression and epithelial-mesenchymal transition. Cancer Res. 69:2638–2646. 2009. View Article : Google Scholar : PubMed/NCBI
10	Sinha I, Null K, Wolter W, et al: Methylseleninic acid downregulates hypoxia-inducible factor-1α in invasive prostate cancer. Int J Cancer. 130:1430–1439. 2012.PubMed/NCBI
11	Wan J, Chai H, Yu Z, et al: HIF-1α effects on angiogenic potential in human small cell lung carcinoma. J Exp Clin Cancer Res. 30:772011.
12	Hannon GJ: RNA interference. Nature. 418:244–251. 2002. View Article : Google Scholar : PubMed/NCBI
13	Volm M and Koomägi R: Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Res. 20:1527–1533. 2000.PubMed/NCBI
14	Swinson DE, Jones JL, Cox G, et al: Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways. Int J Cancer. 111:43–50. 2004. View Article : Google Scholar : PubMed/NCBI
15	Shyu KG, Hsu FL, Wang MJ, Wang BW and Lin S: Hypoxia-inducible factor 1alpha regulates lung adenocarcinoma cell invasion. Exp Cell Res. 313:1181–1191. 2007. View Article : Google Scholar : PubMed/NCBI
16	Luo F, Liu X, Yan N, et al: Hypoxia-inducible transcription factor-1alpha promotes hypoxia-induced A549 apoptosis via a mechanism that involves the glycolysis pathway. BMC Cancer. 6:262006. View Article : Google Scholar : PubMed/NCBI
17	Liao HY, Wang GP, Gu LJ, et al: HIF-1α siRNA and cisplatin in combination suppress tumor growth in a nude mice model of esophageal squamous cell carcinoma. Asian Pac J Cancer Prev. 13:473–477. 2012.
18	Wang G, Ye Y, Yang X, Liao H, Zhao C and Liang S: Expression-based in silico screening of candidate therapeutic compounds for lung adenocarcinoma. PLoS One. 6:e145732011. View Article : Google Scholar : PubMed/NCBI
19	Xu K, Ding Q, Fang Z, et al: Silencing of HIF-1alpha suppresses tumorigenicity of renal cell carcinoma through induction of apoptosis. Cancer Gene Ther. 17:212–222. 2010. View Article : Google Scholar : PubMed/NCBI
20	Kurokawa T, Miyamoto M, Kato K, et al: Overexpression of hypoxia-inducible-factor 1alpha(HIF-1alpha) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Br J Cancer. 89:1042–1047. 2003. View Article : Google Scholar
21	Theodoropoulos GE, Lazaris AC, Theodoropoulos VE, et al: Hypoxia, angiogenesis and apoptosis markers in locally advanced rectal cancer. Int J Colorectal Dis. 21:248–257. 2006. View Article : Google Scholar : PubMed/NCBI
22	Flamant L, Notte A, Ninane N, Raes M and Michiels C: Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia. Mol Cancer. 9:1912010. View Article : Google Scholar : PubMed/NCBI
23	Yook YJ, Seo YJ, Kang HJ, et al: Induction of hypoxia-inducible factor-1α inhibits drug-induced apoptosis in the human leukemic cell line HL-60. Korean J Hematol. 45:158–163. 2010.
24	Olsson M and Zhivotovsky B: Caspases and cancer. Cell Death Differ. 18:1441–1449. 2011. View Article : Google Scholar

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

HIF‑1α silencing suppresses growth of lung adenocarcinoma A549 cells through induction of apoptosis

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Related Articles